• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: REVISION OPTICS RAINDROP NEAR VISION INLAY; CORNEAL INLAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

REVISION OPTICS RAINDROP NEAR VISION INLAY; CORNEAL INLAY Back to Search Results
Model Number 610-0001
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Corneal Scar (1793); Corneal Clouding/Hazing (1878); Loss of Vision (2139)
Event Date 11/16/2017
Event Type  Injury  
Manufacturer Narrative
The explanted inlay was returned to the manufacturer, and the investigation is underway.The device history record review of the manufacturing lot was performed and there were no discrepancies or unusual findings related to the reported issue.Corneal haze, decreased vision, and corneal scarring are listed in the device labeling as known potential risks.(b)(4).
 
Event Description
The patient underwent implantation of the corneal inlay in the right eye on (b)(6) 2016.Early in the postoperative period, the patient presented with trace diffuse lamellar keratitis (dlk) and a few red blood cells in the interface that resulted from a hemorrhage during flap creation with the femtosecond laser.The patient was treated successfully with routine topical steroids and the event was not considered serious.It should be noted that celluvisc was used intraoperatively, which may have contributed to the dlk.At some time later in the postoperative period (exact date not known), the patient presented with corneal haze and the patient was treated with topical steroids.Approximately one year postoperatively, the patient presented with recurrent central corneal haze and decreased best corrected distance vision (bcdva) from 20/25+ (preoperatively) to 20/50.The inlay was explanted on (b)(6) 2017.The surgeon reports that a dlk-like inflammation was a contributing factor in the development of corneal haze.The source of the dlk was believed to be related to toxins in the sterile instrument case.At last examination on one-week post explant, the patient's bcdva was 20/50-1 with the presence of a mild scar and haze.Additional information will be requested.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RAINDROP NEAR VISION INLAY
Type of Device
CORNEAL INLAY
Manufacturer (Section D)
REVISION OPTICS
25651 atlantic ocean dr.,
ste. a1
lake forest CA 92630 8835
Manufacturer (Section G)
REVISION OPTICS
25651 atlantic ocean dr.,
ste. a1
lake forest CA 92630 8835
Manufacturer Contact
pushpita singh
25651 atlantic ocean dr.,
ste. a1
lake forest, CA 92630-8835
9497072740
MDR Report Key7113786
MDR Text Key94732020
Report Number3005956347-2017-00154
Device Sequence Number1
Product Code LQE
UDI-Device Identifier10850394006013
UDI-Public(01)10850394006013
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150034
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 12/13/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Expiration Date08/08/2019
Device Model Number610-0001
Device Catalogue NumberRD1-1
Device Lot Number002979
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/20/2017
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 11/13/2017
Initial Date FDA Received12/13/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/08/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age55 YR
-
-